Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
Beneish M-Score
-8.69 (As of Today)

The zones of discrimination for M-Score is as such:

An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.

Progenics Pharmaceuticals Inc has a M-score of -8.69 suggests that the company is not a manipulator.

PGNX' s Beneish M-Score Range Over the Past 10 Years
Min: -8.69   Max: 52.2
Current: -8.69

-8.69
52.2

During the past 13 years, the highest Beneish M-Score of Progenics Pharmaceuticals Inc was 52.20. The lowest was -8.69. And the median was -1.79.


Definition

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Progenics Pharmaceuticals Inc for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5803+0.528 * 1.095+0.404 * 1.1886+0.892 * 0.0628+0.115 * 1.1325
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 19.6821+4.679 * -0.3368-0.327 * 2.0305
=-8.69

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Sep15) TTM:Last Year (Sep14) TTM:
Accounts Receivable was $1.52 Mil.
Revenue was 1.396 + 1.937 + 0.248 + -0.571 = $3.01 Mil.
Gross Profit was 1.273 + 1.759 + 0.206 + -0.53 = $2.71 Mil.
Total Current Assets was $97.92 Mil.
Total Assets was $136.91 Mil.
Property, Plant and Equipment(Net PPE) was $2.43 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.52 Mil.
Selling, General & Admin. Expense(SGA) was $17.81 Mil.
Total Current Liabilities was $9.94 Mil.
Long-Term Debt was $0.00 Mil.
Net Income was -10.014 + -11.697 + -10.254 + -12.179 = $-44.14 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was -9.758 + -9.011 + -10.882 + 31.616 = $1.97 Mil.
Accounts Receivable was $41.67 Mil.
Revenue was 41.656 + 1.477 + 1.815 + 2.968 = $47.92 Mil.
Gross Profit was 41.487 + 1.33 + 1.733 + 2.652 = $47.20 Mil.
Total Current Assets was $131.10 Mil.
Total Assets was $172.08 Mil.
Property, Plant and Equipment(Net PPE) was $2.32 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.58 Mil.
Selling, General & Admin. Expense(SGA) was $14.41 Mil.
Total Current Liabilities was $6.15 Mil.
Long-Term Debt was $0.00 Mil.



1. DSRI = Days Sales in Receivables Index

Measured as the ratio of days’ sales in receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.519 / 3.01) / (41.667 / 47.916)
=0.50465116 / 0.86958427
=0.5803

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.759 / 47.916) / (1.273 / 3.01)
=0.98509892 / 0.89966777
=1.095

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than plant, property and equipment to total assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (97.924 + 2.428) / 136.912) / (1 - (131.099 + 2.321) / 172.079)
=0.26703284 / 0.22465844
=1.1886

4. SGI = Sales Growth Index

Ratio of sales in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3.01 / 47.916
=0.0628

5. DEPI = Depreciation Index

Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.584 / (0.584 + 2.321)) / (0.524 / (0.524 + 2.428))
=0.2010327 / 0.17750678
=1.1325

6. SGAI = Sales, General and Administrative expenses Index

The ratio of SGA expenses in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(17.814 / 3.01) / (14.408 / 47.916)
=5.91827243 / 0.30069288
=19.6821

7. LVGI = Leverage Index

The ratio of total debt to total assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase$sgai= in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 9.942) / 136.912) / ((0 + 6.154) / 172.079)
=0.07261599 / 0.03576264
=2.0305

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-44.144 - 0 - 1.965) / 136.912
=-0.3368

An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.

Progenics Pharmaceuticals Inc has a M-score of -8.69 suggests that the company will not be a manipulator.


Related Terms

Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
DSRI 2.9840.07011.08510.74927.77821.86820.062327.62060.74160.0067
GMI 1111.00021.00461.02630.97431.03191.04760.9281
AQI 1.12253.33051.4860.66960.34811.55460.56941.61755.07380.6274
SGI 0.99067.36941.08210.89460.72330.162510.66350.16570.55975.6445
DEPI 0.74744.05230.65240.62270.67371.33530.96541.20741.00071.5919
SGAI 1.08850.22271.15841.15521.20385.59780.0754.86451.77420.1813
LVGI 0.97181.2360.73361.40930.21842.95340.53171.36750.50970.7175
TATA -0.4292-0.0744-0.0245-0.10370.1669-0.3716-0.0999-0.0103-0.0564-0.0579
M-score -2.663.35-2.23-3.634.21-5.324.9320.72-1.680.59

Progenics Pharmaceuticals Inc Quarterly Data

Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15
DSRI 0.51210.35670.74160.96822.311715.89120.00670.03240.01590.5803
GMI 0.9750.95191.04761.05281.06470.98660.92810.92770.92071.095
AQI 5.65775.07825.07380.71290.93810.64950.62740.82820.821.1886
SGI 1.16451.87210.55970.53040.5083.47755.64455.74556.07130.0628
DEPI 1.04061.02461.00070.95781.36441.44581.59191.4731.26911.1325
SGAI 0.82230.48371.77351.68671.77010.28980.18140.19240.208519.6821
LVGI 0.66020.3680.50970.36410.6750.72120.71751.24151.41642.0305
TATA -0.0404-0.018-0.0564-0.0053-0.02120.207-0.0579-0.0577-0.063-0.3368
M-score -0.96-0.46-1.68-2.96-1.7914.510.590.600.76-8.69
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK